New drug CMAB017 enters human trials for Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage trial tests a new drug called CMAB017 in 55 people with advanced solid tumors (like head and neck cancer or colorectal cancer) that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see how the body…
Phase: PHASE1 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 26, 2026 16:17 UTC